Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastrointestinal Cancer, Metastatic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05278728
What this trial is testing

Phase IIa Study of Nimotuzumab to Treat Colorectal Cancer

Who this might be right for
Colorectal Cancer
Biotech Pharmaceutical Co., Ltd. 31
Testing effectiveness (Phase 2)Ended earlyNCT02508077
What this trial is testing

FOLFIRI and Panitumumab in Treating Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer

Who this might be right for
Recurrent Colorectal CarcinomaStage IVA Colorectal CancerStage IVB Colorectal Cancer
City of Hope Medical Center 1
Testing effectiveness (Phase 2)Study completedNCT03458975
What this trial is testing

Targeted Delivery of Chemotherapy With Ultrasound and Microbublles

Who this might be right for
Colorectal CancerHepatic Metastases
University Hospital, Tours 7
Testing effectiveness (Phase 2)Study completedNCT00416767
What this trial is testing

Combination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors of the Duodenum or Pancreas That Cannot Be Removed By Surgery

Who this might be right for
Gastrointestinal Carcinoid TumorIslet Cell TumorNeoplastic Syndrome
Federation Francophone de Cancerologie Digestive 20
Early research (Phase 1)Study completedNCT02959905
What this trial is testing

Treatment of Advanced Solid Tumors With TSA-CTL(Tumor Specific Antigen-Induced Cytotoxic T Lymphocytes)

Who this might be right for
Solid Cancer
BGI, China 11
Not applicableNot Yet RecruitingNCT05531045
What this trial is testing

18FFDG PET/CT for Early Evaluation of Chemotherapy Efficacy in Metastatic Colic Adenocarcinoma

Who this might be right for
Metastatic Colorectal Cancer
Assistance Publique - Hôpitaux de Paris 222
Testing effectiveness (Phase 2)Ended earlyNCT00459901
What this trial is testing

Study of the Antitumor Activity of Capecitabine in Combination With Erlotinib in Patients With Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Peter Kozuch 13
Not applicableStudy completedNCT00976612
What this trial is testing

Nilotinib Pharmacokinetics (PK) in Gastrointestinal Stromal Tumor (GIST): Nilotinib PK

Who this might be right for
Gastrointestinal Stromal Tumors
Asan Medical Center 17
Testing effectiveness (Phase 2)Study completedNCT03693677
What this trial is testing

First Line Metastatic Pancreatic Cancer : 5FU/LV+Nal-IRI, Gemcitabine+Nab-paclitaxel or a Sequential Regimen of 2 Months 5FU/LV+Nal-IRI

Who this might be right for
Metastatic Pancreatic Cancer
Federation Francophone de Cancerologie Digestive 288
Testing effectiveness (Phase 2)Study completedNCT01210911
What this trial is testing

Metformin Combined With Chemotherapy for Pancreatic Cancer

Who this might be right for
Locally Advanced Pancreatic CancerMetastatic Pancreatic Cancer
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 120
Post-approval studies (Phase 4)Study completedNCT03700411
What this trial is testing

Influence of Opioid Analgesia on Circulating Tumor Cells in Open Colorectal Cancer Surgery

Who this might be right for
Colorectal CancerCirculating Tumor Cell
The Institute of Molecular and Translational Medicine, Czech Republic 125
Testing effectiveness (Phase 2)Study completedNCT00215644
What this trial is testing

Matuzumab Treatment With Epirubicin, Cisplatin and Capecitabine (ECX) in Esophago-Gastric Cancer

Who this might be right for
Esophageal CancerGastric Cancer
Merck KGaA, Darmstadt, Germany 72
Not applicableUnknownNCT01292681
What this trial is testing

Multi-modality Imaging in the Prediction of Response to Systemic Treatment in Colorectal Cancer

Who this might be right for
Colorectal Cancer
Radboud University Medical Center 60
Testing effectiveness (Phase 2)Looking for participantsNCT05771181
What this trial is testing

Vitamin E Combined With Fruquintinib and Tislelizumab in Microsatellite Stabilized Metastatic Colorectal Cancer Patients

Who this might be right for
Colorectal CancerMicrosatellite Stable Colorectal Carcinoma
Fudan University 25
Large-scale testing (Phase 3)Looking for participantsNCT07222800
What this trial is testing

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Who this might be right for
Intestinal NeoplasmsGastrointestinal NeoplasmsDigestive System Neoplasms+7 more
Pfizer 800
Early research (Phase 1)Study completedNCT01189929
What this trial is testing

Gemcitabine and Demcizumab (OMP-21M18) With or Without Abraxane® as 1st-line Treatment in Subjects With Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
OncoMed Pharmaceuticals, Inc. 57
Not applicableStudy completedNCT05226572
What this trial is testing

Repeated EUS-guided Fine Needle Biopsy of Pancreatic Masses After Non-diagnostic or Inconclusive Results

Who this might be right for
Pancreatic AdenocarcinomaPancreas CancerPancreas Metastases
University of Bologna 462
Testing effectiveness (Phase 2)Study completedNCT00788957
What this trial is testing

Panitumumab Combination Study With Rilotumumab or Ganitumab in Wild-type Kirsten Rat Sarcoma Virus Oncogene Homolog (KRAS) Metastatic Colorectal Cancer (mCRC)

Who this might be right for
Colon CancerColorectal CancerGastrointestinal Cancer+2 more
NantBioScience, Inc. 177
Early research (Phase 1)Study completedNCT02041481
What this trial is testing

MEK Inhibitor MEK162 in Combination With Leucovorin Calcium, Fluorouracil, and Oxaliplatin in Treating Patients With Advanced Metastatic Colorectal Cancer

Who this might be right for
Recurrent Colon CancerRecurrent Rectal CancerStage IVA Colon Cancer+3 more
City of Hope Medical Center 26
Not applicableUnknownNCT04735900
What this trial is testing

Lead-in FOLICOLOR Trial: Following Therapy Response Through Liquid Biopsy in Metastatic Colorectal Cancer Patients

Who this might be right for
Metastatic Colorectal Cancer
University Hospital, Antwerp 60
Next Page